Home/Filings/4/0001842952-25-000060
4//SEC Filing

Minai-Azary Jennifer Lynn 4

Accession 0001842952-25-000060

CIK 0001842952other

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 5:22 PM ET

Size

5.1 KB

Accession

0001842952-25-000060

Insider Transaction Report

Form 4
Period: 2025-06-06
Minai-Azary Jennifer Lynn
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2025-06-06$0.64/sh+40,010$25,48680,010 total
Footnotes (1)
  • [F1]The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.57 - $0.68. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Issuer

Context Therapeutics Inc.

CIK 0001842952

Entity typeother

Related Parties

1
  • filerCIK 0001844398

Filing Metadata

Form type
4
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:22 PM ET
Size
5.1 KB